• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: OTICON MEDICAL - NEURELEC NEURO ZTI COCHLEAR IMPLANT; NEURO ZTI CLA

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

OTICON MEDICAL - NEURELEC NEURO ZTI COCHLEAR IMPLANT; NEURO ZTI CLA Back to Search Results
Model Number NEURO ZTI CLA
Device Problems Failure to Read Input Signal (1581); Communication or Transmission Problem (2896); Connection Problem (2900)
Patient Problems Failure of Implant (1924); No Clinical Signs, Symptoms or Conditions (4582)
Event Date 03/16/2022
Event Type  Injury  
Event Description
Oticon medical representative reported a connectivity issue with the implant (b)(4).
 
Manufacturer Narrative
This product is neither marketed nor distributed in the us; none was shipped / commercially used in the us.In vivo tests were performed by oticon medical representative on april 2022 and connectivity issue with the cochlear implant neuro zti cla, serial number (b)(4) was observed.Udi : (b)(4).
 
Manufacturer Narrative
While this device has gained initial pma approval, it has not been commercialized, imported or sold in the us and no implantations have been performed as of the date of this report.Follow-up report will be submitted once the root cause identified.The subject device is part of the voluntary field corrective action initiated for neuro zti on october 14th 2021 (international recall #211014).
 
Event Description
Oticon medical representative reported a connectivity issue with the implant (b)(4).The customer did not report the reasons of the explantation.
 
Manufacturer Narrative
While this device has gained initial pma approval, it has not been commercialized, imported or sold in the us and no implantations have been performed as of the date of this report.The subject device is part of the voluntary field corrective action initiated for neuro zti on october 14th 2021 (international recall #211014).
 
Event Description
Oticon medical representative reported a connectivity issue with the implant (b)(6).The customer did not report the reasons of the explantation.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NEURO ZTI COCHLEAR IMPLANT
Type of Device
NEURO ZTI CLA
Manufacturer (Section D)
OTICON MEDICAL - NEURELEC
2720, chemin saint-bernard
porte 14
vallauris, 06220
FR  06220
Manufacturer Contact
adrian ternisien
2720, chemin de saint-bernard
porte 14
vallauris, 06220
FR   06220
MDR Report Key15138118
MDR Text Key304719484
Report Number3016743107-2022-00007
Device Sequence Number1
Product Code MCM
UDI-Device Identifier03663227801842
UDI-Public(01)03663227801842(11)201102(17)231102
Combination Product (y/n)N
Reporter Country CodePK
PMA/PMN Number
P200021
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup,Followup
Report Date 10/31/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date11/02/2023
Device Model NumberNEURO ZTI CLA
Device Catalogue NumberM80184
Device Lot Number20-04758
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 04/07/2021
Initial Date FDA Received08/01/2022
Supplement Dates Manufacturer Received09/20/2021
09/20/2022
Supplement Dates FDA Received10/29/2022
10/31/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured11/02/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-